{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:30:20Z","timestamp":1786980620870,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:00:00Z","timestamp":1641340800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:00:00Z","timestamp":1641340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Esophagus"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s10388-021-00899-x","type":"journal-article","created":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T14:07:06Z","timestamp":1641391626000},"page":"224-232","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Safety and feasibility of esophagectomy following combined neoadjuvant immunotherapy and chemotherapy for locally advanced esophageal cancer: a propensity score matching"],"prefix":"10.1007","volume":"19","author":[{"given":"Zhi-Nuan","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiming","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangbo","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqiang","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,5]]},"reference":[{"key":"899_CR1","doi-asserted-by":"crossref","unstructured":"Zhang SW, Sun KX, Zheng RS et al. Cancer incidence and mortality in China, 2015. JNCC; 2020.","DOI":"10.1016\/j.jncc.2020.12.001"},{"issue":"5","key":"899_CR2","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1002\/cam4.3647","volume":"10","author":"F He","year":"2021","unstructured":"He F, Wang J, Liu L, et al. Esophageal cancer: trends in incidence and mortality in China from 2005 to 2015. Cancer Med. 2021;10(5):1839\u201347.","journal-title":"Cancer Med"},{"issue":"10110","key":"899_CR3","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1016\/S0140-6736(17)31462-9","volume":"390","author":"J Lagergren","year":"2017","unstructured":"Lagergren J, Smyth E, Cunningham D, et al. Oesophageal cancer. Lancet. 2017;390(10110):2383\u201396.","journal-title":"Lancet"},{"key":"899_CR4","doi-asserted-by":"publisher","first-page":"855","DOI":"10.6004\/jnccn.2019.0033","volume":"17","author":"JA Ajani","year":"2019","unstructured":"Ajani JA, D\u2019Amico TA, Bentrem DJ, et al. Esophageal and esophagogastric junction cancers, version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2019;17:855\u201383.","journal-title":"J Natl Compr Cancer Netw."},{"key":"899_CR5","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","volume":"366","author":"P van Hagen","year":"2012","unstructured":"van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074\u201384.","journal-title":"N Engl J Med"},{"issue":"27","key":"899_CR6","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1200\/JCO.2018.79.1483","volume":"36","author":"H Yang","year":"2018","unstructured":"Yang H, Liu H, Chen Y, et al. Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): a phase III multicenter, randomized, open-label clinical trial. J Clin Oncol. 2018;36(27):2796\u2013803.","journal-title":"J Clin Oncol"},{"key":"899_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1245\/s10434-011-2049-9","volume":"19","author":"N Ando","year":"2012","unstructured":"Ando N, Kato H, Igaki H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19:68\u201374.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"899_CR8","doi-asserted-by":"publisher","first-page":"209e22","DOI":"10.1038\/nrc.2016.154","volume":"17","author":"M Yarchoan","year":"2017","unstructured":"Yarchoan M, Johnson BA, Lutz ER, et al. Targeting neoantigens to augment antitumour immunity. Nat Rev Cancer. 2017;17(4):209e22.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"899_CR9","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.annonc.2021.02.004","volume":"32","author":"EC Smyth","year":"2021","unstructured":"Smyth EC, Gambardella V, Cervantes A, et al. Checkpoint inhibitors for gastroesophageal cancers: dissecting heterogeneity to better understand their role in first-line and adjuvant therapy. Ann Oncol. 2021;32(5):590\u20139.","journal-title":"Ann Oncol"},{"issue":"1","key":"899_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21037\/jgo-20-599","volume":"12","author":"D Shen","year":"2021","unstructured":"Shen D, Chen Q, Wu J, et al. The safety and efficacy of neoadjuvant PD-1 inhibitor with chemotherapy for locally advanced esophageal squamous cell carcinoma. J Gastrointest Oncol. 2021;12(1):1\u201310.","journal-title":"J Gastrointest Oncol"},{"issue":"3","key":"899_CR11","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.jtcvs.2020.11.106","volume":"161","author":"S Sihag","year":"2021","unstructured":"Sihag S, Ku GY, Tan KS, et al. Safety and feasibility of esophagectomy following combined immunotherapy and chemoradiotherapy for esophageal cancer. J Thorac Cardiovasc Surg. 2021;161(3):836\u201343.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"899_CR12","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.jtho.2020.10.157","volume":"16","author":"B Li","year":"2021","unstructured":"Li B, Zhang Y, Miao L, et al. Esophagectomy with three-field versus two-field lymphadenectomy for middle and lower thoracic esophageal cancer: long-term outcomes of a randomized clinical trial. J Thorac Oncol. 2021;16(2):310\u20137.","journal-title":"J Thorac Oncol"},{"key":"899_CR13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205\u201313.","journal-title":"Ann Surg"},{"issue":"1","key":"899_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/SLA.0b013e318296c732","volume":"258","author":"K Slankamenac","year":"2013","unstructured":"Slankamenac K, Graf R, Barkun J, et al. The comprehensive complication index: a novel continuous scale to measure surgical morbidity. Ann Surg. 2013;258(1):1\u20137.","journal-title":"Ann Surg"},{"key":"899_CR15","doi-asserted-by":"publisher","first-page":"614640","DOI":"10.3389\/fonc.2021.614640","volume":"11","author":"N Kastelowitz","year":"2021","unstructured":"Kastelowitz N, Marsh MD, McCarter M, et al. Impact of radiation dose on postoperative complications in esophageal and gastroesophageal junction cancers. Front Oncol. 2021;11:614640.","journal-title":"Front Oncol"},{"key":"899_CR16","doi-asserted-by":"crossref","unstructured":"Fabbi M, De Pascale S, Ascari F, et al. Side-to-side esophagogastric anastomosis for minimally invasive Ivor-Lewis esophagectomy: operative technique and short-term outcomes. Updates Surg. 2021.","DOI":"10.1007\/s13304-021-01054-y"},{"key":"899_CR17","first-page":"2265","volume":"17","author":"RB D'Agostino","year":"1998","unstructured":"D\u2019Agostino RB. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stated. 1998;17:2265\u201381.","journal-title":"Stated"},{"key":"899_CR18","first-page":"e211555","volume":"12","author":"F van Workum","year":"2021","unstructured":"van Workum F, Verstegen MHP, Klarenbeek BR, et al. Intrathoracic vs cervical anastomosis after totally or hybrid minimally invasive esophagectomy for esophageal cancer: a randomized clinical trial. JAMA Surg. 2021;12:e211555.","journal-title":"JAMA Surg"},{"issue":"5","key":"899_CR19","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1001\/jamasurg.2021.0135","volume":"156","author":"J Hallet","year":"2021","unstructured":"Hallet J, Jerath A, Turgeon AF, et al. Association between anesthesiologist volume and short-term outcomes in complex gastrointestinal cancer surgery. JAMA Surg. 2021;156(5):479\u201387.","journal-title":"JAMA Surg"},{"key":"899_CR20","doi-asserted-by":"publisher","unstructured":"Naidoo J, Wang X, Woo KM, et al. Pneumonitis in patients treated with anti-programmed death-1\/programmed death ligand 1 therapy. J Clin Oncol. 2017;35(7):709\u2013717. https:\/\/doi.org\/10.1200\/JCO.2016.68.2005. (epub 2016 Sep 30; erratum in: J Clin Oncol. 2017;35(22):2590).","DOI":"10.1200\/JCO.2016.68.2005"},{"issue":"1","key":"899_CR21","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.athoracsur.2018.02.030","volume":"106","author":"MJ Bott","year":"2018","unstructured":"Bott MJ, Cools-Lartigue J, Tan KS, et al. Safety and feasibility of lung resection after immunotherapy for metastatic or unresectable tumors. Ann Thorac Surg. 2018;106(1):178\u201383.","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"899_CR22","doi-asserted-by":"publisher","first-page":"e217","DOI":"10.1016\/j.athoracsur.2017.03.038","volume":"104","author":"JE Chaft","year":"2017","unstructured":"Chaft JE, Hellmann MD, Velez MJ, et al. Initial experience with lung cancer resection after treatment with T-cell checkpoint inhibitors. Ann Thorac Surg. 2017;104(3):e217\u20138.","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"899_CR23","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/cac2.12153","volume":"41","author":"J Kang","year":"2021","unstructured":"Kang J, Zhang C, Zhong WZ. Neoadjuvant immunotherapy for non-small cell lung cancer: state of the art. Cancer Commun (Lond). 2021;41(4):287\u2013302.","journal-title":"Cancer Commun (Lond)"}],"container-title":["Esophagus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10388-021-00899-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10388-021-00899-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10388-021-00899-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T23:09:11Z","timestamp":1647299351000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10388-021-00899-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,5]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["899"],"URL":"https:\/\/doi.org\/10.1007\/s10388-021-00899-x","relation":{},"ISSN":["1612-9059","1612-9067"],"issn-type":[{"value":"1612-9059","type":"print"},{"value":"1612-9067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,5]]},"assertion":[{"value":"5 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and its later versions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"There are no conflicts of interest or financial ties to disclose from any authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}